Facilities and equipment used in the manufacturing of drug substances are not adequately maintained.
Inspection Record
Linhai Tianyu Pharmaceutical Co., Ltd. — FDA 483 Findings
Inspectors Arsen Karapetyan · Anders W. EvensonThe inspectors who signed the published document.Inspector lookup
View the regulator's official source The source document is always the basis for judgement.
Findings
Laboratory records are not completed contemporaneously and do not include complete data derived from all tests to assure compliance with established specifications and standards.
Appropriate controls are not exercised over computers or related systems to assure that changes in quality control records are instituted only by authorized personnel.
Similar findings at other companies
GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.
A record as of the US FDA document published on 2026-11-13. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.